Importantly, we found that the HTNV MAP could stimulate IFN-γ production and proliferation of the specific CD8+ T cells of HLA-A*02+ patients with HFRS ex vivo, which may provide the basis for the development of a novel HTNV peptide vaccine. Here, IFNG is linked to hemorrhagic fever with renal syndrome.